Newsroom

We invite you to learn how we promote healing through our product portfolio of cryopreserved amniotic membrane and umbilical cord birth tissue products to treat ocular surface disease, complex and surgical wounds, and musculoskeletal disease and injury.

Press Coverage

Amniox Awarded National Agreements with Premier, Inc. and The Resource Group for Birth Tissue Skin Grafting Products

Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company TissueTech was awarded a group purchasing agreement with Premier, Inc. and The Resource Group on April 1, 2021.

Surgical Repair of Chronic Refractory Macular Holes Using AmnioGraft Cryopreserved Amniotic Membrane

Bio-Tissue announced the case series outcome of surgical repair of large macular holes using AmnioGraft Cryopreserved Amniotic Membrane. Results have shown that the placement of AmnioGraft may be a feasible alternative to conventional surgical methods to improve anatomic and visual outcomes. ShareShareTweetPin

SAWC Spotlight: Amniox Discusses Company Developments

Our primary goal is to be the industry leader in birth tissue regenerative medicine—driving our transition from a leader in the tissue space to an emerging biotech company. ShareShareTweetPin

How TissueTech Managed Growth, Virtual Trials, And Survived COVID-19

Since its inception in 1997, TissueTech has been a pioneer in the clinical application of human birth tissues. The company’s products have been used in more than 500,000 human transplants across multiple indications, under the regulatory classification of human cell and tissue products (HCT/Ps). ShareShareTweetPin

How Women Entrepreneurs Can Pitch Their Ideas With Great SuccessPitching an idea for a new venture is much more challenging if you’re a woman.

Amy Tseng heads up the biotech company TissueTech, which received $110 million in funding. Her background is in business and finance, and she has a keen eye for a profitable opportunity. She likes to keep R&D pipelines fully loaded to identify new markets for “leveraging our core technology.” ShareShareTweetPin

Read All

Upcoming Events

Sep24
Sep 24 - 25, 2021
Bio-Tissue
Nov03
Nov12
Nov 12, 2021
Amniox

Click here to access TissueTech’s Experts Directory

The 2020 TissueTech Experts Directory is a reference tool designed for those seeking commentary on a wide variety of topics ranging from the treatment of ocular surface disease to the management of advanced wounds and traumatic injuries.

MEDIA CONTACT INFORMATION: Journalists may contact TissueTech, Inc. by emailing media@tissuetechinc.com